| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ABBV
AbbVie
|
Jul 10, 2026 | BUY |
Strong Buy
-6.7% avg upside
46 analysts
|
$295.00
18.91% Upside
|
+0.0% |
|
GILD
Gilead Sciences
|
Jul 09, 2026 | BUY |
Strong Buy
-8.3% avg upside
66 analysts
|
$165.00
27.01% Upside
|
-3.7% |
|
REGN
Regeneron
|
Jul 08, 2026 | HOLD |
Strong Buy
+16.2% avg upside
58 analysts
|
$700.00
5.32% Upside
|
+0.2% |
|
MRK
Merck & Company
|
Jul 08, 2026 | BUY |
Strong Buy
+4.0% avg upside
43 analysts
|
$150.00
21.41% Upside
|
-1.9% |
|
VERA
Vera Therapeutics
|
Jul 07, 2026 | BUY |
Strong Buy
+69.4% avg upside
19 analysts
|
$70.00
66.67% Upside
|
-2.8% |
|
VRTX
Vertex Pharmaceuticals
|
Jul 06, 2026 | BUY |
Strong Buy
-9.5% avg upside
61 analysts
|
$550.00
13.38% Upside
|
-8.3% |
|
PFE
Pfizer
|
Jun 22, 2026 | HOLD |
Buy
+39.2% avg upside
45 analysts
|
$28.00
15.87% Upside
|
-3.6% |
|
HALO
Halozyme
|
Jun 15, 2026 | HOLD |
Strong Buy
-22.4% avg upside
20 analysts
|
$75.00
1.60% Downside
|
+6.9% |
|
TVTX
Travere Therapeutics
|
Jun 11, 2026 | BUY |
Strong Buy
-16.8% avg upside
22 analysts
|
$65.00
14.94% Upside
|
+18.3% |
|
SMMT
Summit Therapeutics
|
Jun 02, 2026 | BUY |
Strong Buy
+91.5% avg upside
27 analysts
|
$30.00
96.77% Upside
|
+3.8% |
|
LLY
Eli Lilly & Co
|
May 27, 2026 | BUY |
Strong Buy
-13.6% avg upside
47 analysts
|
$1280.00
7.66% Upside
|
+9.8% |
|
BIIB
Biogen
|
May 22, 2026 | BUY |
Strong Buy
+24.2% avg upside
52 analysts
|
$250.00
25.47% Upside
|
+2.8% |
|
BNTX
BioNTech SE
|
May 22, 2026 | BUY |
Strong Buy
+49.1% avg upside
26 analysts
|
$140.00
52.98% Upside
|
+1.5% |
|
BMY
Bristol-Myers Squibb
|
May 22, 2026 | HOLD |
Buy
+2.3% avg upside
42 analysts
|
$60.00
4.17% Upside
|
-2.1% |
|
BMRN
BioMarin Pharmaceutical
|
May 21, 2026 | BUY |
Strong Buy
+59.6% avg upside
52 analysts
|
$75.00
26.88% Upside
|
+9.3% |
|
JAZZ
Jazz Pharmaceuticals
|
May 06, 2026 | BUY |
Strong Buy
-9.6% avg upside
35 analysts
|
$265.00
8.78% Upside
|
+7.9% |
|
IRWD
Ironwood Pharma
|
May 05, 2026 | HOLD |
Buy
+165.7% avg upside
23 analysts
|
$5.00
11.94% Upside
|
-6.2% |
|
AMGN
Amgen
|
Apr 02, 2026 | HOLD |
Buy
-17.8% avg upside
57 analysts
|
$390.00
7.24% Upside
|
+5.2% |
|
WVE
Wave Life Sciences
|
Apr 01, 2026 | BUY |
Strong Buy
+255.1% avg upside
28 analysts
|
$13.00
107.92% Upside
|
-8.5% |
|
MLYS
Mineralys Therapeutics, Inc.
|
Mar 13, 2026 | BUY |
Strong Buy
+58.6% avg upside
12 analysts
|
$55.00
93.83% Upside
|
+8.4% |
|
NBIX
Neurocrine
|
Feb 13, 2026 | BUY |
Strong Buy
-1.8% avg upside
37 analysts
|
$175.00
1.25% Downside
|
+43.0% |
|
MIST
Milestone Pharmaceuticals
|
Dec 16, 2025 | BUY |
Strong Buy
+547.3% avg upside
7 analysts
|
$8.00
525.09% Upside
|
-40.9% |
|
XENE
Xenon
|
Aug 12, 2025 | BUY |
Strong Buy
-8.6% avg upside
28 analysts
|
$47.00
31.75% Downside
|
+76.1% |
|
ARWR
Arrowhead Pharmaceuticals
|
Jul 02, 2021 | BUY |
Strong Buy
-13.4% avg upside
26 analysts
|
$95.00
24.31% Upside
|
-43.0% |
|
FTH
Faeth Therapeutics
|
Jun 29, 2021 | BUY |
Strong Buy
+14.5% avg upside
13 analysts
|
$14.00
61.35% Downside
|
· |
|
NMTRQ
9 Meters Biopharma
|
Jun 04, 2021 | BUY |
Buy
+3234374900.0% avg upside
11 analysts
|
$3.00
299999899.94% Upside
|
· |
|
PLRX
Pliant Therapeutics
|
Apr 05, 2021 | BUY |
Buy
+1889.7% avg upside
21 analysts
|
$52.00
4542.88% Upside
|
-80.9% |
|
FBRX
Forte Biosciences
|
Mar 26, 2021 | BUY |
Strong Buy
-7.3% avg upside
14 analysts
|
$75.00
70.77% Upside
|
-94.9% |
|
IDYA
IDEAYA Biosciences
|
Mar 24, 2021 | BUY |
Strong Buy
+32.0% avg upside
29 analysts
|
$33.00
10.73% Downside
|
-45.3% |
|
CHRS
Coherus Biosciences
|
Feb 25, 2021 | BUY |
Buy
+715.2% avg upside
18 analysts
|
$27.00
1653.34% Upside
|
-23.1% |
|
STTK
Shattuck Labs
|
Jan 20, 2021 | BUY |
Strong Buy
+249.8% avg upside
14 analysts
|
$75.00
1029.46% Upside
|
-85.9% |
|
AGIO
Agios Pharma
|
Dec 23, 2020 | BUY |
Strong Buy
+47.3% avg upside
29 analysts
|
$65.00
57.66% Upside
|
-18.2% |
|
CTMX
CytomX Therapeutics
|
Sep 15, 2020 | HOLD |
Strong Buy
+189.9% avg upside
21 analysts
|
$8.50
126.01% Upside
|
-31.2% |
|
ADAPY
Adaptimmune Therapeutics
|
Apr 27, 2020 | BUY |
Buy
+6945.4% avg upside
10 analysts
|
$5.00
15051.48% Upside
|
· |
|
AVTR
Avantor
|
Jun 11, 2019 | BUY |
Buy
+39.2% avg upside
26 analysts
|
$21.00
102.17% Upside
|
-5.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.